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Results
Calcitonin gene related peptide dose-dependently inhibited basal gastric acid secretion in awake, freely moving rats (Fig. 1) . One nmol/calcitonin gene related peptide decreased the two hour total acid output by 72%. The lowest peptide dose, 1 pmol, still inhibited acid output by 40% (p<0.01). The half-maximal effective dose was 10 pmol per animal or 44 pmol/kg. Calcitonin gene related peptide (2-2 nmol) decreased both the mean±SE volume from 4*1±0.3 to 1-4±0.4 ml/2 h and the hydrogen ion concentration from 107±8 to 39±10 mM (n=6; p<O.Ol).
Neither the N-terminal fragment, CGRP1 14, nor the C-terminal residue, [Tyr23]CGRP2337, were biologically active ( Fig. 2) . Also, the linear, cysteine
Calcitonin gene related peptide inhibited pentagastrin stimulated gastric acid secretion from the 20 min to the 110 min period in anaesthetised rats (Fig.  3 , upper panel). Similarly, calcitonin gene related peptide inhibited gastric secretion in response to histamine (Fig. 3, middle panel) and the cholinergic agent bethanecol (Fig. 3, lower panel) . The inhibitory effect of calcitonin gene related peptide was most pronounced during the first 60 minutes and steadily ceased towards the end of the study (Fig. 4 ). (Fig. 4 ). with the respective controls (Fig. 5) .
Discussion
Over the past years, a number of gastrointestinal peptides have been shown to inhibit gastric acid secretion including secretin,9 cholecystokinin, 10 Gastric acid secretion was determined as described in Fig. 4 and the two hour total acid outputs were calculated. A bolus injection of calcitonin gene related peptide inhibited gastric acid secretion in response to a maximal dose of either pentagastrin, histamine, or bethanecol. Secretin and neurotensin also inhibited pentagastrin, but not histamine stimulated gastric acid secretion. 12 22 Gastric inhibitory peptide decreased acid secretion stimulated by pentagastrin, histamine, and insulin." While gastric inhibitory peptide was more potent in inhibiting pentagastrin than histamine stimulated acid secretion,"1 calcitonin gene related peptide appears to decrease gastric acid secretion similarly in response to these two secretagogues. Calcitonin gene related peptide inhibits acid secretion stimulated by pentagastrin, histamine, and bethanecol which are thought to act through receptors on the parietal cell.23 Therefore, it is tempting to speculate that calcitonin gene related peptide might interfere with a common pathway of the acid secretory process at or near the parietal cell that is shared by those three secretagogues.
Calcitonin gene related peptide is widely distributed in nerve fibres of blood vessels and visceral organs. In summary, calcitonin gene related peptide, a novel neuropeptide, administered intravenously is a potent inhibitor of basal as well as pentagastrin, histamine, and bethanol stimulated gastric acid secretion in the rat. The complete 37-residue chain including the N-terminal disulphide bridge appears to be required for biological activity. Inhibition of gastric acid secretion by calcitonin gene related peptide may be mediated by a vagal, cholinergic pathway. 
